Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells that interfere with normal blood cell production.
We are studying how safe and effective a combination of Decitabine and Cedazuridine is for cancer patients with kidney problems. This research aims to improve treatment options for those affected.
Health conditions and diseases that the clinical trial is designed to study and treat.
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells that interfere with normal blood cell production.
Myelodysplastic Syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells, leading to ineffective blood cell production and a risk of progression to leukemia.
Solid tumors are abnormal masses of tissue that can occur in various parts of the body, which may be benign or malignant, and can affect organ function depending on their location.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.